Researchers discover treatment for rare blood cancer

January 29, 2014

University of British Columbia researchers have discovered a potential new treatment for a rare blood cancer that may also point the way to treating other more common diseases.

Paroxysmal nocturnal hemoglobinemia (PNH) is a rare form of cancer characterized by episodic rupture of red cells and the danger of forming in the vascular system. The condition results in becoming vulnerable to attacks by the body's own complement immune system and can lead to complications such as anemia, kidney disease and fatal thromboses.

In a clinical study published today in PLOS ONE, the UBC team, led by Prof. Patrick McGeer, applied aurin tricarboxylic acid (ATA), a non-toxic drug, to blood samples of five patients with PNH who were undergoing standard with antibodies administered through biweekly infusions.

The researchers found the addition of ATA restored blood cell resistance to complement system attacks, while the antibodies alone did not offer full protection.

"Our study suggests that ATA could offer more complete protection as an oral treatment for PNH while eliminating the need for infusions," says Prof. McGeer, professor emeritus in UBC's Department of Psychiatry. "PNH is a disease that may happen to anyone through a chance mutation, and if nature were to design a perfect fix for this mutation, it would be ATA."

McGeer adds that since many diseases are caused or worsened by an overactive complement immune system, the discovery of ATA's effectiveness in this rare disease could have wide-reaching implications for conditions such as Alzheimer's and Parkinson disease, macular degeneration, ALS, multiple sclerosis and rheumatoid arthritis.

The team is now proceeding with further testing and McGeer hopes the treatment may be available in clinics within a year.

Related Stories

Cancer drug a possible treatment for multiple sclerosis

February 21, 2013

(Medical Xpress)—A drug that is currently used for cancer can relieve and slow down the progression of the autoimmune disease multiple sclerosis (MS) in rats, according to a new study published in PLOS ONE. The discovery, ...

Certain mutations affect kidney disease risk and prognosis

February 21, 2013

Certain gene mutations affect individuals' risk of developing a serious kidney condition, as well as their prognosis after being diagnosed with the disease, according to a study appearing in an upcoming issue of the Journal ...

New discovery on early immune system development

November 12, 2013

Researchers at Lund University have shed light on how and when the immune system is formed, raising hope of better understanding various diseases in children, such as leukaemia.

Researchers pursuing arthritis protein

January 10, 2014

Researchers at the University of Copenhagen have investigated a special protein that appears in inflammatory diseases such as arthritis, inflammatory bowel disease and psoriasis. The findings have just been published in the ...

Recommended for you

Study reveals new insight into DNA repair

August 3, 2015

DNA double-strand breaks (DSBs) are the worst possible form of genetic malfunction that can cause cancer and resistance to therapy. New information published this week reveals more about why this occurs and how these breaks ...

Strange circular DNA may offer new way to detect cancers

July 30, 2015

Strange rings of DNA that exist outside chromosomes are distinct to the cell types that mistakenly produced them, researchers have discovered. The finding raises the tantalizing possibility that the rings could be used as ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.